|
|
Rapid Cycling Bipolar Disorder: Another niche indication?Published by: Datamonitor Published: Aug. 31, 2003 - 38 Pages Table of ContentsTABLE OF CONTENTS About Datamonitor 2 Executive Summary 5 Introduction 5 Scope and coverage of the brief 5 Key findings about rapid cycling bipolar disorder 5 Introduction 8 Diagnositc criteria 8 Epidemiology 10 Prevalence rate of bipolar disorders 10 Drug Treatment 14 Introduction 14 Mood stabilizers 14 Antidepressants 20 Antipsychotics 21 Other pharmacotherapies 24 Common combination pharmacotherapies 25 Treatment strategies 26 Review of treatments 27 Datamonitor conclusions 28 Unmet Market Needs 30 Strategic Recommendations 32 Increased awareness 32 Treatment guidelines 32 Shared risk scheme 32 Appendix 33 Bibliography 33 Websites 37 AbstractIntroductionRapid cycling bipolar disorder (RCBD) is a market with many unmet needs, although barriers to entry are high. Pharmaceutical manufacturers need to invest substantial money into clinical trials to show a drug’s efficacy, although at first glance, a low diagnosed population and poorly defined treatment strategy offers intangible returns. Scope * Epidemiology of RCBD, including prevalence and diagnosis rates * Analysis of current drug treatment, which includes mood stabilizers, antidepressants, and antipsychotics * Identification of unmet market needs * Datamonitor’s strategic recommendations Report Highlights Datamonitor believes combination therapy is the future of RCBD management. The recommended approach is for add-on rather than initial co-therapy. However, improved, better defined, and standardized treatment guidelines should be published. The treatment strategy for rapid cycling bipolar is major barrier to the quality of treatment. Datamonitor believes that this is not due to a lack of efficacious drugs, but that low levels of research into drug combinations has resulted in an unclear treatment strategy. Reasons to Purchase * Identify current treatment options and unmet needs in the market * Assess market opportunities and potential, and the barriers to market entry * Understand the role of government in defining treatment strategies Get Full Details About This Report >> |
|
|||
|
About MarketResearch.com
|
||||